Breaking News Instant updates and real-time market news.

BA

Boeing

$261.91

0.47 (0.18%)

, HII

Huntington Ingalls

$235.44

1.51 (0.65%)

08:26
10/13/17
10/13
08:26
10/13/17
08:26

Deutsche Bank likes three Defense names into Q3 results

Ahead of the Aerospace & Defense earnings season which begins on October 18, Deutsche Bank analyst Myles Walton says he likes Boeing (BA), Huntington Ingalls (HII) and Raytheon (RTN) into the reports. Helping support the quarter was continued strong air traffic demand, inflecting defense spending outlays, and the increasing geopolitical threat environment, Walton tells investors in a research previewing the earnings for the sector. The analyst increased some price targets in the space, including Huntington Ingalls to $260 from $240, Barnes Group (B) to $77 from $70, Hexcel (HXL) to $66 from $60 and Spirit AeroSystems (SPR) to $83 from $75.

BA

Boeing

$261.91

0.47 (0.18%)

HII

Huntington Ingalls

$235.44

1.51 (0.65%)

RTN

Raytheon

$188.91

1.69 (0.90%)

B

Barnes Group

$71.51

1.02 (1.45%)

HXL

Hexcel

$60.11

0.81 (1.37%)

SPR

Spirit AeroSystems

$79.19

0.46 (0.58%)

  • 22

    Oct

  • 25

    Oct

  • 27

    Oct

  • 08

    Nov

  • 04

    May

BA Boeing
$261.91

0.47 (0.18%)

10/09/17
BARD
10/09/17
NO CHANGE
Target $325
BARD
Outperform
Boeing upside remains despite year-to-date run, says Baird
Baird analyst Peter Arment said he continues to see upside in Boeing shares despite its 66% run year-to-date. The analyst said the year's move is a reflection of the company's ongoing execution, robust free cash flow generation, and the emerging new leg of growth with BGS. Arment tells investors to stay long and he reiterated his Outperform rating and $325 price target on Boeing shares.
10/06/17
ADAM
10/06/17
NO CHANGE
Target $235
ADAM
Hold
Boeing acquisition leverages defense and commercial business, says Canaccord
Canaccord analyst Ken Herbert noted Boeing announced it agreed to acquire Aurora Flight Sciences, which allows it to gain access to leading technology in both its military and commercial platforms. The deal will have limited financial impact, but it will give Boeing the opportunity to be at the forefront of autonomous innovation, said Herbert, who maintained his Hold rating and $235 price target on Boeing shares.
10/09/17
RBCM
10/09/17
NO CHANGE
Target $209
RBCM
Outperform
Defense and Aerospace sector poised for strong Q3, says RBC Capital
RBC Capital analyst Matthew McConnell previewed the Q3 earnings season for the defense and commercial aviation industries, raising price targets across the sectors. In defense, McConnell likes the companies with focus on international markets, where demand has not yet been reflected in orders or backlog. Among his favorites, McConnell raises the price target on Raytheon (RTN) to $209 from $193, General Dynamics (GD) to $241 from $220, Northrop Grumman (NOC) to $324 from $294, Lockheed Martin (LMT) to $327 from $289, and Triumph (TGI) to $38 from $33. He also states that there may be room for some consolidation in defense given that budget up-cycle is only 2 years old, profiling Astronics (ATRO), Barnes (B), Esterline (ESL), Heico (HEI), and Textron (TXT) as some of the potential targets. In commercial aviation, McConnell sees Boeing (BA) upside driven by continued strong air traffic growth, mature sales campaigns, and expectations for a strong wide-body replacement cycle starting in the early 2020s, raising his price target on Boeing to $269 from $235.
09/22/17
JEFF
09/22/17
NO CHANGE
Target $300
JEFF
Buy
Boeing price target raised to $300 from $275 at Jefferies
Jefferies analyst Howard Rubel raised his price target for Boeing shares to $300 following the company's recent investor day. The analyst boosted his 2019 earnings per share estimate to $12.10 from $12.00 and 2020 estimate to $13.25 from $12.85. Mid-single digit air traffic growth and a "well-considered" plan to increase the 787 line to 14 per month in 2019 should drive Commercial Aircraft deliveries from 748 in 2016 to about 915 by 2020, Rubel tells investors in a research note titled "Building One Boeing from Three Units and Four Million Parts." He keeps a Buy rating on the shares.
HII Huntington Ingalls
$235.44

1.51 (0.65%)

02/21/17
FBCO
02/21/17
NO CHANGE
Target $225
FBCO
Neutral
Huntington Ingalls price target raised to $225 from $203 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Huntington Ingalls to $225 from $203 following quarterly results. The analyst reiterates a Neutral rating on the shares.
03/01/17
SBSH
03/01/17
DOWNGRADE
SBSH
Neutral
Northrop Grumman downgraded to Neutral from Buy at Citi
Citi analyst Jason Gursky downgraded Northrop Grumman (NOC) to Neutral saying Defense stocks are now reaching fair value. The analyst this morning also downgraded to Neutral shares of Huntington Ingalls (HII) and General Dynamics (GD). Gursky keeps Buy ratings on Harris (HRS), L3 Technologies (LLL), Lockheed Martin (LMT) and Raytheon (RTN).
03/01/17
SBSH
03/01/17
DOWNGRADE
SBSH
Neutral
Huntington Ingalls downgraded to Neutral from Buy at Citi
Citi analyst Jason Gursky downgraded Huntington Ingalls to Neutral saying Defense stocks are now reaching fair value.
01/12/17
01/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Overweight from Equal Weight at Morgan Stanley to Buy from Neutral at Guggenheim, and to Overweight from Neutral at Piper Jaffray. 2. Huntington Ingalls (HII) upgraded to Buy from Neutral at BofA/Merrill with analyst Ronald Epstein saying he expects ship building to be a significant beneficiary of a Trump administration increase in defense spending and its strategy to improve the U.S.' global presence without committing ground troops. The analyst said Huntington Ingalls is a pure play on U.S. Navy growth and raised its price target to $230 from $180. 3. Fastenal (FAST) upgraded to Outperform from Market Perform at Avondale with analyst Lawrence Pfeffer saying he is growing increasingly confident that the earnings revision cycle has turned for the better for Fastenal and the broader short-cycle industrial groups due to the improving industrial landscape. The analyst raised his price target to $54 from $51. 4. Fluor (FLR) upgraded to Buy from Hold at Deutsche Bank with analyst Chad Dillard saying the company is one of the biggest beneficiaries of a bookings recovery in Oil & Gas while its "robust project pipeline" for 2017 is underappreciated. The analyst raised his price target for the shares to $63 from $48. 5. Cameco (CCJ) was upgraded to Neutral from Underperform at BofA/Merrill and to Buy from Speculative Buy at TD Securities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,click here.
RTN Raytheon
$188.91

1.69 (0.90%)

09/29/17
DBAB
09/29/17
UPGRADE
DBAB
Buy
Raytheon upgraded to Buy from Hold at Deutsche Bank
09/29/17
DBAB
09/29/17
UPGRADE
Target $210
DBAB
Buy
Deutsche sees rise in missile defense spending, upgrades Raytheon
Deutsche Bank analyst Myles Walton upgraded Raytheon (RTN) to Buy from Hold and raised his price target for the shares to $210 from $180. Raytheon is the most exposed to missile defense trends, Walton told investors earlier in a research note. He believes the politics and growing missile threats to U.S. territory are "setting the table for another leg up" in missile defense spending after declining nearly 25% over the last decade. The analyst sees his other Buy-rated defense names, including Northrop Grumman (NOC) and Lockheed Martin (LMT), benefiting as well. Walton raised his price target for Northrop to $325 from $285 and for Lockheed to $340 from $305.
09/29/17
09/29/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Southern Company (SO) upgraded to Outperform from Sector Perform at RBC Capital with analyst Shelby Tucker is increasingly convinced that the regulators are "committed to completing" the company's Vogtle project. 2. Conn's (CONN) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Nagel saying the company's credit business, under new CEO Norm Miller, is "on a much more solid footing, and supportive of a return to expansion in retail." 3. Raytheon (RTN) upgraded to Buy from Hold at Deutsche Bank with analyst Myles Walton saying Raytheon is the most exposed to missile defense trends. 4. USA Truck (USAK), J.B. Hunt (JBHT), and Heartland Express (HTLD) were upgraded to Buy from Hold at Stifel. 5. Zynerba (ZYNE) upgraded to Overweight from Neutral at Piper Jaffray analyst Charles Duncan saying without over-interpreting the results from this "modest open-label program," the data establish an "activity signal and tolerability profile that merits further placebo-controlled study." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
B Barnes Group
$71.51

1.02 (1.45%)

07/31/17
OPCO
07/31/17
NO CHANGE
Target $67
OPCO
Outperform
Barnes Group price target raised to $67 from $58 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Barnes Group to $67 from $58 as organic momentum "surged," with short-term Industrial operating inefficiencies neutralizing the impact, and tax benefit defining the EPS guidance raise. He reiterates an Outperform rating on the shares.
09/14/17
RHCO
09/14/17
NO CHANGE
RHCO
Boeing production increase positive for suppliers, says SunTrust
SunTrust analyst Michael Ciarmoli says that Boeing's (BA) decision to increase its production to 14 planes per month in 2019, up from 12 currently, was "surprising" to many investors, including him, who expected the company to maintain or cut its current production level. He thinks that the decision increases the chances that the 2018 and 2019 estimates for airplane suppliers will rise. The analyst says that the following companies can benefit from Boeing's production increase: Astronics (ATRO), Barnes Group (B),Rockwell Collins (COL), KLX Inc. (KLXI), Spirit AeroSystems (SPR),Triumph Group (TGI), Wesco Aircraft (WAIR),and Woodward (WWD),
04/24/17
SIDC
04/24/17
DOWNGRADE
SIDC
Neutral
Barnes Group downgraded to Neutral from Buy at Sidoti
HXL Hexcel
$60.11

0.81 (1.37%)

07/26/17
VERT
07/26/17
DOWNGRADE
VERT
Hold
Hexcel downgraded to Hold from Buy at Vertical Research
Vertical Research analyst Robert Stallard downgraded Hexcel to Hold with a $54 price target saying the Q2 report was modestly below consensus and Aerospace sales were lower than expected.
09/28/17
LOOP
09/28/17
INITIATION
LOOP
Hold
Hexcel initiated with a Hold at Loop Capital
Loop Capital analyst Chris Kapsch initiated Hexcel with a Hold rating and $61 price target.
04/21/17
COWN
04/21/17
NO CHANGE
Target $57
COWN
Outperform
Hexcel dip should be bought, says Cowen
Cowen analyst Gautam Khanna said he would be a buyer of the dip in Hexcel shares despite its Q1 setback. He believes the company will return to its upward grind given accelerating 2018 earnings, high short interest and the firm's scarcity. Khanna reiterated his Outperform rating and $57 price target on Hexcel shares.
02/06/17
BOFA
02/06/17
UPGRADE
BOFA
Buy
Hexcel upgraded to Buy from Neutral at BofA/Merrill
SPR Spirit AeroSystems
$79.19

0.46 (0.58%)

09/26/17
SBSH
09/26/17
NO CHANGE
Target $85
SBSH
Buy
Spirit AeroSystems could rally above $100 on higher production, says Citi
Citi analyst Jason Gursky says his firm's free cash analysis shows a path to $100 per share for Spirit AeroSystems. Higher production rates could support a share price above $100, Gursky tells investors in a research note. The 2020s are "shaping up nicely from a production rate perspective" as 737, 787 and 777 could all see growth, the analyst writes. He keeps a Buy rating on Spirit with an $85 price target.
09/28/17
JEFF
09/28/17
NO CHANGE
Target $90
JEFF
Buy
Spirit AeroSystems price target raised to $90 from $84 at Jefferies
Jefferies analyst Howard Rubel raised his price target for Spirit AeroSystems (SPR) to $90 saying executing its supply and pricing agreement with Boeing (BA) eliminates an uncertainty and creates a structure for sharing operational gains. Following the company's investor conference, the analyst believes opportunities in the defense, fabrication and commercial aircraft markets should drive Spirit's revenue growth at a mid-single digit rate. He keeps a Buy rating on the name.
09/28/17
ADAM
09/28/17
NO CHANGE
Target $86
ADAM
Buy
Spirit AeroSystems price target raised to $86 from $80 at Canaccord
Canaccord analyst Ken Herbert raised his price target on Spirit AeroSystems to $86 from $80 following its investor day presentation. The analyst cited the company's focus on revenue generation and execution as well as its aggressiveness on its cost structure. Herbert reiterated his Buy rating on Spirit AeroSystems shares.

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.